Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Die Da Injury Ointment is a traditional Chinese medicine (TCM) topical formulation developed by Yiwu Zhenwei Chinese Herbal Medicine Technology Development Co., Ltd. It is specifically indicated for the treatment of acute soft tissue contusions, particularly those presenting with the TCM pattern of Qi stagnation and blood stasis. The ointment is composed of multiple herbal extracts traditionally used in 'Die Da' (traumatic injury) medicine to promote blood circulation, resolve stasis, and alleviate pain and swelling. It has been evaluated in multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical trials in China to assess the efficacy and safety of different dosage strengths in providing pain relief for adults with acute injuries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Die Da Injury Ointment.